
zzso remains a significant cause of morbidity and mortality in zzso zzso zzso zzso has been used with success in adult patients but has not been studied in the pediatric zzso To estimate the effectiveness of zzso for the treatment of zzso in pediatric patients, we zzso reviewed the charts of 19 patients zzso age 4 zzso range zzso zzso with grades II zzso zzso zzso III zzso zzso 10), or IV zzso zzso 6) zzso who received zzso zzso Patients received a median dose of zzso zzso zzso zzso zzso zzso divided over 2-6 zzso zzso percent of patients received additional zzso A complete response, defined as zzso of grade 0 at four zzso following the first zzso course, was observed in nine patients zzso A partial response, defined as an improvement in grade after four zzso was observed in five patients zzso There was no response in five patients zzso The overall response rate at four zzso was zzso zzso complications included zzso zzso presumed or documented zzso infections zzso zzso zzso zzso zzso zzso zzso and zzso zzso zzso We conclude that zzso is effective for zzso in pediatric patients with a tolerable spectrum of zzso 

